These final results, along with a former report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the strategy of targeting ACKR3 as a novel approach to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related Problems.Importantly, these receptors were disc